Xia Tao

Xia Tao


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
CHCuiyun Huang
Cuiyun Huang
SQShi Qiu
Shi Qiu
XFXiangcheng Fan
Xiangcheng Fan
GJGuangyang Jiao
Guangyang Jiao
XZXun Zhou
Xun Zhou
WCWansheng Chen
Wansheng Chen
Shengxian Decotion (SXT), a well-known Traditional Chinese Medicine (TCM) formula composed of Astragali Radix, Bupleuri Radix, Cimicifugae Rhizoma, Anemarrhenae Rhizoma and Platycodonis Radix, is clinically considered as an effective formula against cardiovascular diseases. However, the exact effective substance of SXT in treating chronic heart failure (CHF) still remains unclear. In the current study, we investigated the benefit of SXT in doxorubicin (DOX)-induced CHF rats and established a UHPLC-MS/MS method to simultaneously determine 18 key compounds in a subsequent comparative pharmacokinetic study in normal and CHF rats. Histopathological studies, transmission electron microscopy, and echocardiography were applied to assess the therapeutic effect of SXT on DOX-induced CHF rats, which indicated that SXT significantly ameliorated DOX-induced CHF, similar to enalapril. In addition, we successfully established a UHPLC-MS/MS method to determine the pharmacokinetics of the components in rat plasma, which was validated with good linearity, inter-day and intra-day precisions and accuracies, matrix effects, extraction recovery, and stability values. Our results showed that only astragaloside IV showed increased plasma exposure in the CHF rats, while saikosaponin A, quercetin, timosaponin B-II, ferulic acid, isoferulic acid and formononetin decreased compared to their pharmacokinetic characteristics in the normal and CHF rats. This study demonstrates that SXT enjoys obvious therapeutic effect on DOX-induced CHF rats, and the altered metabolism of some compounds in SXT is affected by the pathological state of CHF rats. Our findings provide a better understanding of the in vivo exposure to complex compounds of SXT, supporting effective substance screening and further investigation of the therapeutic mechanism.

5 September 2023 in Blood Cancer Journal
Verified
Journal Article
Open access
PDF file
WQWanting Qiang
Wanting Qiang
LJLina Jin
Lina Jin
TLTiancheng Luo
Tiancheng Luo
YJYanchun Jia
Yanchun Jia
JLJing Lu
Jing Lu
JDJuan Du
Juan Du

23 May 2024 in World Journal of Traditional Chinese Medicine
Verified
Journal Article
Open access
FZFeng Zhang
Feng Zhang
NWNan Weng
Nan Weng
JZJian-Xiu Zhai
Jian-Xiu Zhai
GJGuang-Yang Jiao
Guang-Yang Jiao
YWYe-Jian Wang
Ye-Jian Wang
WCWansheng Chen
Wansheng Chen
Objective: The study aimed to establish an effective strategy for systematically characterizing and verifying compounds in Huangkui capsules (HKCs). Materials and Methods: An ultrahigh-performance liquid chromatography quadrupole time-of-flight mass spectrometry (MS) method was effectively established and utilized for the chemical compound characterization in HKC, with the support of MS-DIAL, MS-FINDER, and Global Natural Product Social Molecular Network. Multiple rat samples were analyzed after the oral administration. Metabolites were identified based on specific cleavage behaviors, and metabolic pathways were predicted. Semi-quantitative analysis of the metabolome profiles was conducted using post-data processing. High concentrations in vivo were investigated for their role in tacrolimus-induced death of HK-2 cells. Results: In total, 129 compounds were identified in HKC, of which 74 were reported for the first time. In this study, we successfully identified and uncovered 19 prototypes and 123 metabolites from the biosamples. The concentrations of glucuronidation and methylation metabolites of quercetin were the highest in the kidney and intestinal tissues. In contrast, significant glucuronidation of quercetin metabolites was observed with high blood concentrations. Notably, quercetin glucuronidation and methylation metabolites protected HK-cell against tacrolimus-induced injury in a dose-dependent manner. Conclusions: This study successfully established a reliable and efficient strategy for comprehensive characterization of traditional Chinese medicine compounds. This strategy harnessed the power of various intelligent postprocessing technologies to provide a more thorough understanding of active components and their metabolic transformations in the body. These results suggest that quercetin metabolites should be evaluated for their protective capacity against kidney disease.

1 June 2022 in Translational Pediatrics
Verified
Journal Article
Open access
PDF file
YWYan Wen
Yan Wen
MZMengpei Zhao
Mengpei Zhao
SFShangxi Fu
Shangxi Fu
ZGZhichun Gu
Zhichun Gu
WCWansheng Chen
Wansheng Chen
FZFeng Zhang
Feng Zhang
Pharmaceutical services based on therapeutic care pathway for kidney transplantation from donors of infants and young children: a single-center experience Yan Wen, Mengpei Zhao, Shangxi Fu, Zhichun Gu, Wansheng Chen, Qing Zhao, Wei Shu, Xia Tao, Feng Zhang